Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders

Progress in Neurobiology

Volumn 42, Issue 6, 1994, Pages 685-702

  Onodera, Kenji ^a   Yamatodani, Atsushi ^b   Watanabe, Takehiko ^c   Wadas, Hiroshi ^d  

^a TOHOKU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CHLORPROMAZINE; CIMETIDINE; DOXEPIN; DRONABINOL; ENKEPHALIN DERIVATIVE; HALOPERIDOL; HISTAMINE; HISTAMINE AGONIST; MEPYRAMINE; MESORIDAZINE; MOLINDONE; MORPHINE; NALOXONE; NEUROLEPTIC AGENT; PENTAZOCINE; PERPHENAZINE; PHENCYCLIDINE; PYRIMETHAMINE; RANITIDINE; TRIPELENNAMINE; UNINDEXED DRUG; ZOLANTIDINE;

ADDICTION; AGGRESSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; BLOOD PRESSURE; CIRCADIAN RHYTHM; DEMENTIA; FOOD INTAKE; HISTAMINERGIC SYSTEM; HUMAN; NEUROANATOMY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0028343237     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-0082(94)90017-5     Document Type: Review

References (302)

1. Histaminergic neurons: Comparative anatomy in the central nervous system of vertebrates
2. The histaminergic system in the guinea pig central nervous system: Immunocytochemical mapping study an antiserum against histamine
3. Comparative neuro-anatomy of the histaminergic system in the brain of the frog Xenopus labis
4. Histaminergic system in the tree shrew brain
5. Histamine neurons in human hypothalamus: Anatomy in normal and Alzheimer disease brains
6. Multiple neurotransmitters in the tuberomammillary nucleus: Comparison of rat, mouse and guinea pig
7. Further evidence that histamine in hippocampus affects the exploratory behavior in the rat
8. Histamine in dorsal and ventral hippocampus. II. Effects of H1 and H2 histamine antagonists on exploratory behavior in male rats
9. The role of histamine in the anterior hypothalamus and its functional interaction with the hippocampus on exploratory behavior in adult male rats
10. Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
11. Autoregulation of histamine release in brain by presynaptic H3-receptors
12. Autoinhibition of histamine synthesis mediated by presynaptic H3 receptors
13. Highly potent and selective ligands for histamine H3 receptoss
14. Phencyclidine blocks histamine H3-receptors in rat brain
15. H3-Receptors control histamine release in human brain
16. Modification of rat thermal responses to morphine by FMH suggests a role for neuronal histamine in morphine tolerance
17. Development of histamine-immunoreactive neurons in the rat brain
18. Activity of antihistamins in laboratory antidepressant test
19. Endogenous pain control system: Brainstem spinal pathways and endorphin circuitry
20. Localization of histidine decarboxylase mRNA in rat brain
21. Some behavioural effects of histamine H1 antagonists in squirrel monkeys
22. Antinociceptive effect of intracerebroventricularly administered histamine in rats
23. Effect of prolonged inhibition of histidine decarboxylase on tissue histamine concentrations
24. Temperature changes following microinjection of histamine into the thermoregulatory centers of the rat
25. Biphasic effects of intra accumbens histamine administration on spontaneous motor activity in the rat: A role for central histamine receptors
26. Distribution of histaminergic neurons in the brain of the lamprey Lampetra fluviatilis as revealed by histamine-immunoreactivity
27. Wernicke's encephalopathy in a child with acute lymphoblastic leukemia treated with polychemotherapy]
28. Mainliner and blue velvet
29. Alzheimer's disease: Clinical and therapeutic alternatives
30. Histidine decarboxylase (HDC) inhibition induced by FMH provokes learning-related hypokinetic activity
31. Nature of histaminergic neuromodulation of the release of the corticotropinergic system
32. Neuroendocrine correlates in senile dementia of the Alzheimer type
33. Neuroendocrine function in psychiatric disorders and dementia
34. Brain histamine in Alzeimer's disease
35. Some behavioral effects following intracerebroventricular (i.c.v.) injection in rats of histamine H1- and H2-receptor agonists and antagonists
36. The distribution of histidine decarboxylase mRNA in the rat brain: An in situ hybridyzation study using synthetic oligonucleotide probes
37. The mechanism of the potentiating effects of antidepressant drugs on the protective influence of diphenhydramine in experimental catalonia. The role of histamine
38. Analgesic effect of histamine induced by intracerebral injection into mice
39. The effect of antihistaminic drugs on convulsive seizures
40. Evidence for histamine H3 receptor regulation of drinking in the rat
41. Thioperamide a selective histamine H3 receptor antagonist inhibits amphetamine- and apomorphine-induced locomotor activity in the mouse
42. 3H]acetylcholine from sites of rat entorhinal cortex: Evidence for the possible existence of H3 receptor subtypes
43. Changes in body temperature after administration of acetylcholine, histamine, morphine, prostaglandins and related agents
44. Biphasic changes in body temperature produced by intracerebroventicular injections of histamine in the cat
45. Changes in body temperature after administration of acetylcholine, histamine, morphine, prostaglandins and related agents: II
46. Histamine intraventricular injection suppresses ingestive behavior of cat
47. Histamine: Effect of self-stimulation
48. Histamine-induced rise in core temperature of chloral-aneasthetized rats: Mediation by H2-receptors located in the preoptic area of hypothalamus
49. Increase in histamine concentations in hypothalamic nuclei of spontaneously hypertensive rats
50. Alzheimer's disease: A disorder of cortical cholinergic innervation
51. Cerebral histamine levels are unaffected by MPTP administration in the mouse
52. Inhibition of rat brain histamine N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA)
53. Memory facilitation by histamine
54. Intracerebroventricular histamine, but not 48/80, causes posttraining memory facilitation in the rat
55. Spinal antagonism of tolerance and dependence induced by systemically administered morphine
56. Analysis of histamine receptors in the central thermoregulatory response in rats
57. Histamine turnover in rat brain
58. Histamine as an extremely potent releaser of vasopressin in the rat
59. Induction of proclactin and luteinizing hormone release by histamine in male and female rats and the influence of brain transmitter antagonists
60. Acute effects of histamine on plasma prolactin and luteinizing hormone levels in male rat
61. Increase in plasma catecholamines by intraventricular injection of histamine in conscious rats
62. Effect of a histamine synthesis inhibitor antihistamines on the sexual behavior of female rats
63. Histamine, 5-hydroxytryptamine (serotonin) and their antagonists
64. Hormones, feeding and temperature in sheep following cerebroventricular injections of neurotransmitters and carbachol
65. Morphological analysis of the tubermammillary nucleus of the rat brain: Delineation of subgroups with antibody against l-histidine decarboxylase as a marker
66. Brainstem afferents to the tuberomammillary nucleus in the rat brain with special reference to monoaminergic innervation
67. Origin of neuronal inputs to the region of the tuberomammillary nucleus of the rat brain
68. GABA-like immunoreactivity in the tuberomammillary nucleus in the rat brain: Delineation of subgroups with antibody against l-histidine decarboxylase as a marker
69. Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital
70. The cardiovascular effects of intraventricularly administered histamine in the anaesthetized rat
71. H2-receptor blockers and mental confusion
72. Dual control of adrenocorticotrophin release
73. Histaminergic H1 antagonists modulate seizure pattern induced by electroshock in mice
74. Elevation of histamine levels but not H2-receptor blockade influences electrically-induced seizure threshold in mice
75. Neuronal histamine modulates feeding behavior through H1-receptor in rat hypothalamus
76. Hypothalamic histamine modulates adaptive behaviour in rats at high environmental temperature
77. Recent developments in brain histamine research: Pathways and receptors
78. Brain histidine decarboxylase activity in Parkinson's disease
79. Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists
80. Studies on the possible role of brain histamine in behavior
81. Studies on the effects of histaminergic agents on seizure susceptibility in mice
82. Stress and brain histaminergic system: Effects of weak electric footshock
83. Opiate-like and abstinence-like effects of intracerebral histamine administration in rats
84. H2-receptor-mediated stress-induced analgesia is dependent on neither pituitary nor adrenal activation
85. Effects of zolantidine, a brain penetrating H2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia
86. Histamine as a punisher in squirrel monkeys: Effects of pentobarbital, chlordiazepoxide and H1- and H2-receptor antagonists on behavior and cardiovascular responses
87. Tricyclic antidepressant drugs block histamine H2-receptor in brain
88. Antagonism of histamine-activated adenylated cyclase in brain by d-lysergic acid diethylamide
89. Histamine as a neurotransmitter
90. Histamine H1- and H2-receptors in the central thermoregulatory pathways of the rat
91. Site and mechanisms of action of histamine in the central thermoregulatory pathways of the rat
92. Two outward currents in histamine neurons of the rat hypothalamus in vitro
93. Membrane properties of histaminergic tuberomammillary neurons of the rat hypothalamus in vitro
94. Fine structure of histaminergic neurons in the caudal magnocellular nucleus of the rat as demonstrated by immunocytochemistry using histidine decarboxylase as a marker
95. Histamine-sensitive adenylate cyclase in mammalian brain
96. Effect of unilateral vestibular stimulation on histamine release from the hypothalamus of rats in vivo
97. Cellular localization and possible functions for brain histamine: Recent progress
98. Modulation of morphine antinociception by antagonism of H2 receptors in the Periaqueductal gray
99. Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists
100. Zolantidine-induced attenuation of morphine antinociception in rhesus monkeys
101. Cimetidine-induced mania
102. Mental confusion associated with ranitidine
103. The effect of tripelennamine alone and in combination with opiates to produce antinociception in mice
104. Histamine H1 receptors are increased in parietal epilepsy: A PET study
105. The histaminergic innervation of the mesencephalic nucleus of the trigeminal nerve in the rat brain: A light and electron microscopic study
106. Organization of histaminergic fibers in the rat brain
107. An analysis of histaminergic efferents of the tuberomammillary nucleus to the medial preoptic area and inferior colliculus of the rat
108. Organization of the histaminergic system in the brain of the turtle, Chinemys reevesii
109. Organization of the histaminergic system in the brain of the teleost, Trachurus trachurus
110. Epileptogenic side effects of psychotropic drugs
111. Neuronal histamine inhibits methamphetamine-induced locomotor hyper-activity in mice
112. Comparison of effects of phencyclidine and methamphetamine on body temperature in mice. A possible role for histamine neurons in thermoregulation
113. Involvement of mu receptors in the opioid-induced increase in the turnover of mouse brain histamine
114. Effects of nociceptive stimuli on brain histamine dynamics
115. Changes in the feeding of rats elicited by histamine infusion
116. Effect of histamine depletion on circadian variation of corticotropin and corticosterone in rats
117. Effects of histamine and α-fluoromethylhistidine injections on circadian phase of free-running rhythms
118. Effect of histamine depletion on the circadian amplitude of the sleep-wakefulness cycle
119. Effects of intracerebroventricular histamine injection on circadian activity phase entrainment during rapid illumination changes
120. Histamine-induced arousal in the conscious and pentobarbital-pretreated rat
121. Participation of histamine in the step-through active avoidance response and its inhibition by H1-blockers
122. Cataleptic effect of histamine induced by intraventricular injection in mice
123. Influence of certain H1-blockers on the step-through active avoidance response in rats
124. Influence of histamine depletion on learning and memory recollection in rats
125. Effect of famotidine on deficit symptoms of schizophrenia
126. Interactions with psychotropic drugs
127. Brain histamine receptors as targets for antidepressant drugs
128. Further analysis of the specificity of a novel animal model of depression-effects of an antihistaminic, antipsychotic and anxiolytic compound
129. Effect of centrally administered histamine on body temperature in guinea-pigs
130. Pyribenzamine activation of the electroencephalogram
131. Effects of α-fluoromethylhistidine on sleep-waking parameters in rats
132. Drug effects on active immobility responses: What they tell us about neurotransmitter systems and motor functions
133. Effect of histamine on the secretion of pro-opiomelanocortin derived peptides in rats
134. The effect of stress and environmental lighting on histamine in the rat brain
135. Lack of effects of astemizole on vestibular ocular reflex, motion sickness, and cognitive performance in man
136. The cytoarchitecture, histochemistry, and projections of the tuberomammillary nucleus in the rat
137. Galanin immunoreactivity in hypothalamic histamine neurons: Further evidence for multiple chemical messengers in the tuberomammillary nucleus
138. Pentazocine and tripelenamine: A drug abuse epidemic?
139. The clinical pharmacology of pentazocine and tripelennamine (T's and blues) Problems of drug dependence
140. Famotidine: An update review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases
141. Thiamine deficiency and alcoholism
142. Histamine: A stimulatory effect on drinking behavior in the rat
143. Effects of antihistamines on naloxone-induced withdrawal in morphine-dependent mice
144. The histamine H3-receptor: A target for developing new drugs
145. Actions of morphine on histamine dynamics in the mouse brain: A strain comparison
146. Differential effects of morphine on histamine metabolism in brain and spinal cord of mice
147. Evidence for histaminergic arousal mechanism in the hypothalamus of cat
148. Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat
149. α-Fluoromethylhistidine but not diphenhydramine prevents motion-induced emesis in the cat
150. Is the brain histamine involved in cataleptogenic action of analgesics and haloperidol?
151. Catalepsia-like symptoms produced by histidine in rats
152. The effects of chronic morphine treatment on histamine concentration and histidine decarboxylase activity in rat brain
153. Alterations in brain endogenous histamine levels in rats after chronic morphine treatment and morphine withdrawal
154. Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer's patients
155. Age-related changes in brain histamine
156. The Korsakoff syndrome: A neurochemical perspective
157. Stimulant actions of histamine H1 antagonists on operant behavior in the squirrel monkey
158. Relative potencies of histamine H1 antagonists as behavioral stimulants in the squirrel monkey
159. Neurochemical studies on central histaminergic neuron system of senescence accelerated mice
160. Regional distribution of histamine in the brain of non-mammalian vertebrates
161. In vivo release of neuronal histamine in the hypothalamus of rats measured by microdialysis
162. Circadian rhythm of histamine release from the hypothalamus of freely-moving rats
163. Effects of H1- and H2-histamine receptor agonists and antagonists on sleep and wakefulness in the rat
164. Effects of α-fluoromethylhistidine on sleep and wakefulness in the rat
165. Phenylpropanolamine, a non-prescription drug with potentially fatal side effects
166. Involvement of histaminergic mechanisms in the cataleptogenic effect of morphine in mice
167. Study on histamine H1 receptor in brains from schizophrenics and parkinsonians
168. Evidence for central histaminergic mechanism in foot shock aggression
169. Role of central histamine mechanism in behavioural depression (swimming despair) in mice
170. Influence of brain histamine system on episodic growth hormone secretion in the rat
171. Antihistamines and sedation
172. New antihistamines free of sedative side effects
173. Histaminergic systems and sleep: Studies in man with H1 and H2 antagonists
174. Antihistamines: Impaired performance and the tendency to sleep
175. Sedation and histamine H1-receptor antagonism: Studies in man with the enantiomers of chlorpheniramine and dimethindene
176. The in vivo pharmacological profile of histamine (H1) antagonists in the rat
177. Morphine-induced changes in histamine dynamics in mouse brain
178. Mechanism of the central hyperglycemic action of histamine in mice
179. Central effects of histamine H1 and H2 receptor agonists and antagonists after intraventricular infusion in fowls
180. The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking
181. The influence of mepyramine and burimamide on histamine-induced catalepsy in the rat
182. Does histamine interact with cholinergic neurons in its cataleptogenic action in rats?
183. Dimaprit-induced hypothermia in normal rats: Its attention by cimetidine and by tricyclic antidepressant drugs
184. Decreased histamine turnover in the brain of spontaneously hypertensive rats
185. 9-Tetrahydrocannabinol decreases turnover of brain histamine
186. Diazepam-induced decrease in histamine turnover in mouse brain
187. Histamine turnover in the brain of morphine-dependent mice
188. Age-dependent increase of histamine content in rat mast cells
189. Effects of antidepressants and antihistaminics on catalepsy induced by intracerebroventricular administration of histamine in mice
190. Aggressive behavior in thiamine deficient rats and histaminergic system
191. The effect of intraventricular injection of histamine on the behavior in mice and rats
192. Opiate-like actions by intracerebroventricular histamine in mice and its antagonism by naloxone
193. Effects of histaminergic drugs on muricide induced by thiamine deficiency
194. Pharmacological characteristics of catalepsy induced by intracerebroventricular histamine in mice: The importance of muscarinic steps in central cholinergic neurons
195. Regional changes in brain histamine levels following dietary-induced thiamine deficiency in rats
196. Effects of thiamine administration on hypothermia and hypothalamic histamine levels in dietary-induced thiamine deficient rats
197. Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats
198. Effects of α-fluoromethylhistidine on behavior and histamine and catecholamine content in rats
199. Prostaglandin E2 and histamine in the posterior hypothalamus
200. FMH-induced decrease in central histamine levels produces increased feeding and body weight in rats
201. Histamine-containing neurons in the rat hypothalamus
202. Histamine-immunoreactive nerve fibers in the rat brain
203. A histamine-containing neuronal system in human brain
204. Increased neuronal histamine in thiamine-deficient rats
205. Biochemical studies of body fluids in senile dementia of the Alzheimer type (SDAT) and multiinfarct dementia (MID). Correlation analysis between histamine and vasopressin in CSF and plasma
206. Interactions with other neuron systems
207. Hypothalamic superfusion with histamine agonists and antagonists modifies the pressor response to hypothalamic stimulation
208. Histidine-induced bizzare behavior in rats: The possible involvement of central cholinergic system
209. Current trends in the abuse of pentazocine and tripelenamine: The metropolitan St Louis experience
210. Histamine, histidine decarboxylase and histamine N-methyltransferase in brain area of spontaneously hypertensive rats
211. Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans
212. Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid
213. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: Evaluation of abuse liability
214. Alzheimer's disease: A multisystem disorder
215. Studies on the role of central histamine in the acquisition of a radiation-induced conditioned taste aversion
216. Effects of histaminergic drugs on footshock-induced aggressive behavior in rats
217. Possible interrelationship between the biogenic amines involved in the modulation of footshock aggression in rats
218. Electrophysiological properties of cortically projecting histamine neurons of rat hypothalamus
219. Histamine receptors in the central nervous system
220. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro
221. Wernicke's disease: A clinical and pathological study of 42 cases
222. Turnover of neuronal histamine in the mammalian brain and its changes induced by drugs and observed in disease models
223. v mice
224. Effects of (S)-α-fluoromethyl histidine and metoprine on locomotor activity and brain histamine content in mice
225. Modulation of neuronal histamine in control of food intake
226. Hypothalamic pathology in Alzheimer's disease
227. Importance of histamine seizure susceptibility
228. Histamine in brain—its role in regulation of seizure susceptibility
229. Histamine H3-receptor-mediated inhibition of serotonin release in the rat brain cortex
230. A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex
231. The third histamine receptors
232. The toxic effects of antihistaminic drugs
233. Restraint stress stimulation of prolactin and ACTH secretion: Role of brain histamine
234. Clinical experience with T's and B's
235. Coexistence of adenosine deaminase, histidine decarboxylase, and glutamate decarboxylase in hypothalamic neurons of the rat
236. Histamine modulates heat stress-induced changes in blood-brain barrier permeability, cerebral blood flow, brain oedema and serotonin levels. An experimental study in conscious young rats
237. Hypothermia produced in mice by histamine acting on the central nervous system
238. Possible neuronal mechanism involved in neurotensin-induced catalepsy in mice
239. Electroencephalographic activation of “diencephalic epilepsy” with diphenhydramine
240. Effect of α-fluoromethylhistidine upon masculine copulatory behavior of rats
241. Structural relationship and potency of agents which selectively block mouse killing (muricide) behavior in rats
242. Immunohistochemical localization of histamine in neurons and mast cells in the rat brain
243. Histaminergic projections from the premammillary and posterior hypothalamus region to the caudate putamen complex in the rat
244. Possible explanation of T's and Blues' interaction. Tripelennamine (TRIP) and pentazocine (PTZ) are potent ligands for psychotomimetic sigma opioid receptor
245. Pharmacological modulation of the wheating response to histamine in human skin: Identification of doxepin as a potent in vitro inhibitor
246. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type
247. Effect of H1 blockers alone and in combination with morphine to produce antinociception in mice
248. Drug interactions in the reinforcing effects of over-the-counter cough syrups
249. Potentiation of pentazocine conditioned place preference by tripelenamine in rats
250. Effects of histaminergic drugs on development of analgesic tolerance to morphine in mice
251. Pulmonary angiothrombosis caused by “blue velvet” addiction
252. Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice
253. Histaminergic axons in the neostriatum and cerebral cortex of the rat: A correlated light and electron microscope immunocytochemical study using histidine decarboxylase as a marker
254. Aversive effects of drugs: Drugs as punishers in squirrel monkeys
255. Discriminative and aversive properties of β-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys
256. Effects of histamine receptor antagonists on morphine-and U-50,488-induced analgesia
257. A murine new model of accelerated senescence
258. Immunocytochemical evidence for the coexistence of histidine decarboxylase-like and glutamate decarboxylase-like immunoreactivities in nerve cell of the posterior magnocellular nucleus of the hypothalamus of rats
259. Origins of histamine containing fibers in the cerebral cortex of rats studied by immunohistochemistry with histidine decarbxylase as a marker and transection
260. Histaminergic mechanisms of motion sickness: Neurochemical and neuropharmacological studies in rats
261. Histaminergic projection from the posterior hypothalamus to the medial vestibular nucleus of rat and its relation to motion sickness
262. Neuropeptide Y afferents have synaptic interactions with histaminergic (histidine decarboxylase-immunoreactive) neurons in the rat brain
263. Histaminergic neurons receive substance P-ergic inputs in the posterior hypothalamus
264. Excitatory effect of histamine on the arousal system and its inhibition by H1 blockers
265. The effects of histamine and some related compounds on conditioned avoidance response in rats
266. Comparative study of various H1-blockers on neuropharmacological and behavioral effects including 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole difumarate (KB-2413), a new antiallergic agent
267. Brain histamine: Rapid apparent turnover altered by restraint and cold stress
268. Dynamics of the regulation of histamine levels in mouse brain
269. Cimetidine-induced mania in depressed patients
270. Effects of histamine on thermosensitive neurons in preoptic slices preparations
271. Inhibition of the TSH secretion by histamine in male rats
272. Involvement of histamine in circadian and other rhythms
273. Cardiovascular and behavioral changes after i.c.v. infusions of histamine and agonists in conscious goats
274. Vasopressin release by histamine in the conscious goat
275. In vivo release of endogenous catecholamines, histamine and GABA in the hypothalamus of Wistar Kyoto and spontaneously hypertensive rats
276. Is histamine an anticonvulsive inhibitory transmitter?
277. Inhibition of sound-induced convulsions by metoprine in the audiogenic seizure susceptible rat
278. Pharmacological probes of the mammalian circadian clock Use of the phase response curve approach
279. Muricide of rats as an animal model of depression for the nonclinical evaluation of antidepressants
280. Turnover of cerebral histamine in a stressful situation
281. Is the histaminergic neuron system a regulatory center for whole brain activity?
282. Spinal projection of hypothalamic histidine decarboxylase-immunoreactive neurons
283. Distribution of the histaminergic neuron system in the central nervous system of rat; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker
284. Pharmacology of α-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase
285. Effects of chlorpheniramine, pyrilamine and astemizole on intracranial self-stimulation in rats
286. Behavioral effect of histamine and its antagonists. A review
287. The possible role of brain histamine and H1 and H2 receptors in the development of morphine tolerance and physical dependence in mice
288. The effect of I-histidine and of specific histamine receptor agonists, on the expression of morphine tolerance and physical dependence in mice
289. Projection from the prefrontal cortex to histaminergic cell groups in the posterior hypothalamic region of the rat. Anterograde tracing with Phaseolus vulgaris-leucoagglutinin (PHA-L) combined with immunocytochemistry of histidine decarboxylase
290. Innervation of histaminergic neurons in the posterior hypothalamic region by medial preoptic nucleus: Anterograde tracing with Phaseolus vulgaris-leucoagglutinin combined with immunocytochemistry of histidine decarboxylase
291. The connections between the septum-diagonal band complex and histaminergic neurons in the posterior hypothalama of the rat. Anterograde tracing with Phaseolus vulgaris-leucoagglutinin combined with immunocytochemistry ofhistidine decarboxylase
292. The toxic effects of antihistaminic drugs
293. Histaminergic modulation of the dopamine turnover in mouse brain
294. Structure and functions of the histaminergic neurone system
295. Circadian rhythms and brain histamine
296. Age-dependent decrease in histamine H1 receptor in human brains revealed by PET
297. Histamine levels and clonic convulsions of electrically-induced seizure in mice: The effects of α-fluoromethylhistidine and metoprine
298. A histamine H1-antagonist, ketotifen produced seizures in an epileptic child: Activation study of d-chlorpheniramine on EEG
299. Effect of thioperamide, a histamine H3-antagonist on electrically-induced convulsions in mice
300. The proconvulsant effect of histamine H1-antagonists in developing mice
301. Brain histamine turnover enhanced by foot shock